Literature DB >> 1577763

Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing.

C A Johnson1, P Densen, R K Hurford, H R Colten, R A Wetsel.   

Abstract

Two variants of a genetic deficiency of complement protein C2 (C2D) have been previously identified. No C2 protein translation is detected in type I deficiency, while type II deficiency is characterized by a selective block in C2 secretion. Type I C2 deficiency was described in a family in which the C2 null allele (C2Q0) is associated with the major histocompatibility haplotype/complotype HLA-A25,B18,C2Q0,BfS,C4A4, C4B2,Drw2; this extended haplotype occurs in over 90% of C2-deficient individuals (common complotype/haplotype). To determine the molecular basis of type I C2 deficiency, the C2 gene and cDNA were characterized from a homozygous type I C2-deficient individual with the common associated haplotype/complotype. We found a 28-base pair deletion in the type I C2Q0 gene, beginning 9 base pairs upstream of the 3'-end of exon 6, that generates a C2 transcript with a complete deletion of exon 6 (134 base pair) and a premature termination codon. In studies of eight kindred, the 28-base pair deletion was observed in all C2Q0 alleles associated with the common type I deficient complotype/haplotype; this deletion was not present in normal C2 nor in type II C2-deficient genes. These data demonstrate that: 1) type I human complement C2 deficiency is caused by a 28-base pair genomic deletion that causes skipping of exon 6 during RNA splicing, resulting in generation of a premature termination codon, 2) the 28-base pair deletion in the type I C2Q0 gene is strongly associated with the HLA haplotype/complotype A25,B18,C2Q0,BfS,C4A4,C4B2,Drw2, suggesting that all C2-deficient individuals with this haplotype/complotype will harbor the 28-base pair C2 gene deletion, and 3) type II C2 deficiency is caused by a different, as yet uncharacterized, molecular genetic defect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577763

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  The genetic and molecular bases of monogenic disorders affecting proteolytic systems.

Authors:  I Richard
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

2.  Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.

Authors:  B Selander; H Käyhty; E Wedege; E Holmström; L Truedsson; C Söderström; A G Sjöholm
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

3.  Complement components 2 and 7 (C2 and C7) gene polymorphisms are not major risk factors for SLE susceptibility in the Malaysian population.

Authors:  Lay-Hoong Lian; Ai-Sze Ching; Zheng-Yi Chong; Kek-Heng Chua
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

4.  Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE).

Authors:  M A Dragon-Durey; N Rougier; J P Clauvel; S Caillat-Zucman; P Remy; L Guillevin; F Liote; J Blouin; F Ariey; B U Lambert; M D Kazatchkine; L Weiss
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

5.  Recurrent infections, pericarditis and renal disease in a patient with total C2 deficiency and decreased NK cell function consistent with acute rheumatic fever and systemic lupus erythematosus.

Authors:  D B Bittleman; K K Maves; J A Bertolatus; S M Bonsib; P Densen; Z K Ballas; J M Weiler
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

6.  Hajdu-Cheney syndrome.

Authors:  M A O'Reilly; D G Shaw
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

7.  Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations.

Authors:  G N Fredrikson; B Gullstrand; J Westberg; A G Sjöholm; M Uhlén; L Truedsson
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

8.  Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus.

Authors:  Y L Wu; G Hauptmann; M Viguier; C Y Yu
Journal:  Genes Immun       Date:  2009-03-12       Impact factor: 2.676

9.  Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature.

Authors:  Knut Tore Lappegård; Dorte Christiansen; Anne Pharo; Ebbe Billmann Thorgersen; Bernt Christian Hellerud; Julie Lindstad; Erik Waage Nielsen; Grethe Bergseth; Dag Fadnes; Tore G Abrahamsen; E Arne Høiby; Lone Schejbel; Peter Garred; John D Lambris; Morten Harboe; Tom Eirik Mollnes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

Review 10.  Monogenic systemic lupus erythematosus: insights in pathophysiology.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-05-15       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.